EP0420930 - METHOD OF SYNTHESIS AND NOVEL COMPOUNDS FOR PHARMACEUTICAL USES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.12.1993 Database last updated on 15.06.2024 | Most recent event Tooltip | 28.12.1993 | Application deemed to be withdrawn | published on 16.02.1994 [1994/07] | Applicant(s) | For all designated states LALEZARI, Iraj 240 Garth Road Scarsdale, NY 10583 / US | For all designated states LALEZARI, Parviz One Church Lane Scarsdale, NY 10483 / US | [1991/15] | Inventor(s) | 01 /
see applicant ... | [1991/15] | Representative(s) | Roggero, Sergio Ing. Barzanò & Zanardo Milano S.p.A. Via Borgonuovo 10 I-20121 Milano / IT | [1991/15] | Application number, filing date | 89907939.6 | 15.06.1989 | [1991/15] | WO1989US02621 | Priority number, date | US19880207098 | 15.06.1988 Original published format: US 207098 | [1991/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO8912622 | Date: | 28.12.1989 | Language: | EN | [1989/30] | Type: | A1 Application with search report | No.: | EP0420930 | Date: | 10.04.1991 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.12.1989 takes the place of the publication of the European patent application. | [1991/15] | Search report(s) | International search report - published on: | US | 28.12.1989 | (Supplementary) European search report - dispatched on: | EP | 15.10.1991 | Classification | IPC: | C07C127/19 | [1991/15] | CPC: |
C07C273/1827 (EP,US);
A61P3/06 (EP);
A61P7/00 (EP);
A61P7/02 (EP);
C07C233/75 (EP,US);
C07C275/34 (EP,US)
| Designated contracting states | AT, BE, CH, DE, FR, GB, IT, LI, LU, NL, SE [1991/15] | Title | German: | VERFAHREN ZUR HERSTELLUNG SOWIE NEUE VERBINDUNGEN ZUR VERWENDUNG ALS HEILMITTEL | [1991/15] | English: | METHOD OF SYNTHESIS AND NOVEL COMPOUNDS FOR PHARMACEUTICAL USES | [1991/15] | French: | PROCEDE DE SYNTHESE ET NOUVEAUX COMPOSES DESTINES A DES UTILISATIONS PHARMACEUTIQUES | [1991/15] | File destroyed: | 12.06.1999 | Entry into regional phase | 12.12.1990 | National basic fee paid | 12.12.1990 | Search fee paid | 12.12.1990 | Designation fee(s) paid | 12.12.1990 | Examination fee paid | Examination procedure | 12.01.1990 | Request for preliminary examination filed International Preliminary Examining Authority: DE | 12.12.1990 | Examination requested [1991/15] | 14.04.1993 | Despatch of a communication from the examining division (Time limit: M04) | 25.08.1993 | Application deemed to be withdrawn, date of legal effect [1994/07] | 22.09.1993 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [1994/07] | Fees paid | Renewal fee | 14.05.1991 | Renewal fee patent year 03 | 21.05.1992 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.06.1993 | 05   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XP]WO8810113 (LALEZARI IRAJ [US], et al); | [X]FR1571198 ; | [E]EP0358118 (BOEHRINGER MANNHEIM GMBH [DE]) | [XP] - PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 85, no. 16, August 1988, pages 6117-6121; I. LALEZARI et al.: "LR16, a compound with potent effects on the oxygen affinity of hemoglobin, on blood cholesterol, and on low density lipoprotein" | International search | [A]US3020145 (GOBEIL RICHARD J, et al); | [A]DE2614045 (BOEHRINGER MANNHEIM GMBH) |